We examined sequential serum samples from 12 patients with well-characterized posttransfusion non-A, non-B hepatitis who had an acute, resolving self-limited type of clinical course for the presence of antibody to the hepatitis C virus nucleocapsid (core) protein (p22) expressed by a recombinant bac
Detection of an Antigen (AN6520), Possibly Related to Non-A, Non-B Hepatitis, by Monoclonal Antibodies. I
β Scribed by Dr. Toshitaka Akatsuka; Jun-Ichi Tohmatsu; Namiko Yoshihara; Takeshi Odaka; Norimichi Katsuhara; Takeshi Okamoto; Toshio Shikata
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 545 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
β¦ Synopsis
The antibody to AN6520 antigen, which was isolated from the liver of a patient with non-A, non-B hepatitis (NANBH), has been detected frequently in convalescent sera from patients wtih NANBH by the passive hemagglutination (PHA) test. In a further study, we established hybridoma cells secreting antibodies against AN6520 antigen and obtained ascitic fluids with PHA titers ranging from 1: lo5 to 1 : 10' . In immunodiffusion with AN6520 antigen, all monoclonal antibodies were found to form an identical precipitin line. These lines were also identical to those formed by rabbit antiserum against AN6520 antigen and by convalescent sera from patients with NANBH. With one of the monoclonal antibodies, 1-F12, solidphase radioimmunoassay (SP-RIA) for detecting AN6520 antigen was developed as well as blocking RIA for anti-AN6520 antibody detection. The antigen assay was 50 times more sensitive than the reverse passive hemagglutination (R-PHA) test, with a sensitivity threshold of the 1 ng/ml of antigen solution; the antibody assay was 10 times more sensitive than PHA. The results with this blocking RIA were mostly in agreement with the data obtained by PHA. Furthermore, the antigen in human sera, which had never been detected by R-PHA test, could be detected by SP-RIA.
π SIMILAR VOLUMES
## Abstract An antigen was detected by counterelectrophoresis in serum samples from six of seven chimpanzees during the acute phase of experimentally induced nonβA, nonβB hepatitis using antiserum from a chimpanzee convalescent from human nonβA, nonβB hepatitis. This antigen could not be detected i
An enzyme-linked immunosorbent assay (ELISA) was developed based on sera from patients convalescent from non-A, non-B hepatitis and haemophilia A patients who had been frequently treated with commercial blood products. Using this ELISA, an antigen was detected which appears to be related to non-A, n
To further investigate the specificity of the monoclonal antibodies (48-1 and S-1) associated with non-A, non-B hepatitis, extensive immunofluoreecence studies were performed on liver biopsy specimens from chimpanzees with experimental hepatitis A, B, non-A, non-B or 6, or from normal chimpanzees. B
To clarify the relationship between hepatitis C virus infection and the development of hepatocellular carcinoma as sequelae of non-A, non-B posttransfusion hepatitis, 231 patients with chronic non-A, non-B hepatitis (96 with chronic hepatitis, 81 with cirrhosis and 64 with hepatocellular carcinoma)
Chronic infection by the hepatitis B virus (HBV) is a well-Hepatocellular carcinoma (HCC) exhibits a more than established risk factor for HCC. Previously, we have demon-50-fold variation in incidence worldwide. High-risk restrated that up to 90% of HCC cases among high-risk Chinese gions include Ea